The AIMBE Scholars Program enables distinguished postdoctorates in the medical and biomedical engineering fields to serve as expert advisors to policy makers at the FDA. Scholars learn how to apply their experiences from the lab bench to inform regulatory policy decisions. AIMBE Scholars work side-by-side with the most influential decision makers at the agency–from reviewers to FDA scientists to Center directors. They inform public policy through their knowledge of the latest cutting-edge research and technological innovations. Scholars receive training about regulatory science and policy and build relationships with key government stakeholders. Scholars extend the capacity of the FDA and work toward streamlining regulatory processes at the agency through a variety of projects. They may be involved in standards development and the development of metrics to evaluate and inform agency programs and decision-making.
Some biomedical engineers participating in the AIMBE Scholars Program return to their academic, government, or industry careers–with greater understanding of the connections between public policy and translational science–while others go on to build new careers in regulatory policy.
The goals of the AIMBE Scholars Program are twofold:
(1) To advance regulatory science at the FDA and strengthen the connections between bioengineering and the scientific enterprise, industry, and the regulatory processes that governs the medical device sector; and
(2) As a training program for rising leaders in the field to learn first-hand about the regulatory processes that encompass the medical device total product life cycle.
September 16, 2015: AIMBE Announces 2015-2016 Scholars at FDA
September 16, 2015: AIMBE Announces Renewed Partnership with FDA
September 15, 2014: AIMBE Announces 2014-2015 Scholars at FDA
September 1, 2014: AIMBE Launches Scholars Program
AIMBE Scholars Program
The AIMBE Scholars Program is a highly competitive program, consisting of one-year immersion experiences from October 1 to September 31 in the Center for Devices and Radiological Health (CDRH) within the U.S. Food and Drug Administration (FDA) on the White Oak Campus in Silver Spring, MD. AIMBE facilitates the Scholars experience throughout the program year. The program includes an orientation to public policy, as well as opportunities to network with regulatory and R&D leaders in both industry and government. Scholars are provided with a yearly stipend of $70,000, plus allowances for moving expenses to Washington and attendance at scientific conferences throughout the program-year.
Apply Today! Applications deadline is December 5, 2016.
AIMBE is soliciting applications for its October 1, 2017 to September 30, 2018 program year. Applicants to the AIMBE Scholars Program must hold a PhD-level degree in biomedical or biological engineering or a related field, be a U.S. citizen, and have an excellent record of achievement. A current U.S. passport and valid driver’s license are required.
OPEN Call for Applications
Who should apply?
Early career candidates that have a desire to learn first-hand about the regulatory processes and decision-making efforts at FDA in order to advance their career goals. Preference provided to candidates interested in pursuing careers in industry, government, regulatory affairs, and/or R&D.
Candidates may apply to AIMBE to complete the program with an annualized stipend of $70,000, plus allowances for moving expenses to Washington and attendance at scientific conferences throughout the program-year. This opportunity is most suited to early-career candidates within 10 years of receipt of their Ph.D.
How do I apply?
Applications require: (1) a Statement of interest (1,000 word maximum) that describes the applicant’s background and qualifications for the program, basis for interest in the program, including policy areas or issues of interest and skills to be acquired, and career goals, including how the program would support those goals and (2) a current C.V. Applications materials must be submitted to firstname.lastname@example.org by December 5, 2016. Dissertations must be successfully defended and degrees conferred by August 31, 2017 to participate.
Conflict of Interest
AIMBE Scholars are not allowed to have any conflict of interest (COI) or outside involvement with FDA regulated products during their appointments. This includes any outside activities (paid or voluntary) such as research or business in FDA regulated products such as drugs and medical devices. Scholars must follow FDA guidelines regarding COI, financial involvement, and research involvement that apply to all FDA employees.
Sarah Mandell, Director of Research and Programming at AIMBE